ConductScience.org, home

Paper40909165

Advances of bispecific antibodies using/application in dermatology: a review.

Zhang T and 4 others. Front Allergy, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Advances of bispecific antibodies using/application in dermatology: a review. Papers, record 40909165. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40909165

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances of bispecific antibodies using/application in dermatology: a review.
PubMed
Journal
Front Allergy
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang TTing
2Liu YYang
3Liew PXPei Xiong
4Zhang YYu
5Zhao ZZuotao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References119

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131544849Design and Production of Bispecific Antibodies.Antibodies (Basel)2019https://conductscience.org/library/papers/31544849PubMed
229471919Dupilumab: A review of its use in the treatment of atopic dermatitis.J Am Acad Dermatol2018https://conductscience.org/library/papers/29471919PubMed
328887948Psoriasis pathogenesis and the development of novel targeted immune therapies.J Allergy Clin Immunol2017https://conductscience.org/library/papers/28887948PubMed
426271488AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model.Protein Eng Des Sel2015https://conductscience.org/library/papers/26271488PubMed
537305885Psoriasis-like skin rash triggered by a local infection in a patient with eosinophilic granulomatosis with polyangiitis that was well controlled by mepolizumab treatment.Clin Case Rep2023https://conductscience.org/library/papers/37305885PubMed
637629154Role of Innate Immunity in Allergic Contact Dermatitis: An Update.Int J Mol Sci2023https://conductscience.org/library/papers/37629154PubMed
724828435Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19.MAbs2014https://conductscience.org/library/papers/24828435PubMed
837481828Potential roles of inflammasomes in the pathophysiology of Psoriasis: A comprehensive review.Mol Immunol2023https://conductscience.org/library/papers/37481828PubMed
936578492Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis.Front Immunol2022https://conductscience.org/library/papers/36578492PubMed
1027200804Relative Efficacy And Safety of Ustekinumab Compared to Anti-TNF-Alfa Therapies in Patients With Active Psoriatic Arthritis.Value Health2014https://conductscience.org/library/papers/27200804PubMed
1125637431Alternative molecular formats and therapeutic applications for bispecific antibodies.Mol Immunol2015https://conductscience.org/library/papers/25637431PubMed
1228249141Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.N Engl J Med2017https://conductscience.org/library/papers/28249141PubMed
1338547937When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?Pharmacol Res2024https://conductscience.org/library/papers/38547937PubMed
1439726595A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases.Front Immunol2024https://conductscience.org/library/papers/39726595PubMed
1531345627Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.Lancet Oncol2019https://conductscience.org/library/papers/31345627PubMed
1630032191Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis.Rheumatology (Oxford)2018https://conductscience.org/library/papers/30032191PubMed
1739596740Potential Therapeutic Targets for Combination Antibody Therapy Against Staphylococcus aureus Infections.Antibiotics (Basel)2024https://conductscience.org/library/papers/39596740PubMed
1835401191Bispecific Antibodies Progression in Malignant Melanoma.Front Pharmacol2022https://conductscience.org/library/papers/35401191PubMed
1925136781Transforming growth factor β--at the centre of systemic sclerosis.Nat Rev Rheumatol2014https://conductscience.org/library/papers/25136781PubMed
2038650005Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma.J Hematol Oncol2024https://conductscience.org/library/papers/38650005PubMed

See all 119 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42371296Atopic Dermatitis: New Targets and Emerging Systemic Therapies.Am J Clin Dermatol2026https://conductscience.org/library/papers/42371296

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40909165

GET https://conductscience.org/api/papers/v1/40909165/references?page=2